These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 21719468

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dual inhibition of endocannabinoid catabolic enzymes produces enhanced antiwithdrawal effects in morphine-dependent mice.
    Ramesh D, Gamage TF, Vanuytsel T, Owens RA, Abdullah RA, Niphakis MJ, Shea-Donohue T, Cravatt BF, Lichtman AH.
    Neuropsychopharmacology; 2013 May; 38(6):1039-49. PubMed ID: 23303065
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
    Kinsey SG, Long JZ, O'Neal ST, Abdullah RA, Poklis JL, Boger DL, Cravatt BF, Lichtman AH.
    J Pharmacol Exp Ther; 2009 Sep; 330(3):902-10. PubMed ID: 19502530
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice.
    Kinsey SG, Nomura DK, O'Neal ST, Long JZ, Mahadevan A, Cravatt BF, Grider JR, Lichtman AH.
    J Pharmacol Exp Ther; 2011 Sep; 338(3):795-802. PubMed ID: 21659471
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice.
    Gamage TF, Ignatowska-Jankowska BM, Muldoon PP, Cravatt BF, Damaj MI, Lichtman AH.
    Drug Alcohol Depend; 2015 Jan 01; 146():7-16. PubMed ID: 25479915
    [Abstract] [Full Text] [Related]

  • 7. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J, Lai Y, Takacs SM, Bradshaw HB, Hohmann AG.
    Pharmacol Res; 2013 Jan 01; 67(1):94-109. PubMed ID: 23127915
    [Abstract] [Full Text] [Related]

  • 8. Prolonged monoacylglycerol lipase blockade causes equivalent cannabinoid receptor type 1 receptor-mediated adaptations in fatty acid amide hydrolase wild-type and knockout mice.
    Schlosburg JE, Kinsey SG, Ignatowska-Jankowska B, Ramesh D, Abdullah RA, Tao Q, Booker L, Long JZ, Selley DE, Cravatt BF, Lichtman AH.
    J Pharmacol Exp Ther; 2014 Aug 01; 350(2):196-204. PubMed ID: 24849924
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.
    Kinsey SG, O'Neal ST, Long JZ, Cravatt BF, Lichtman AH.
    Pharmacol Biochem Behav; 2011 Mar 01; 98(1):21-7. PubMed ID: 21145341
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB1 receptor-mediated discriminative stimulus in mice.
    Owens RA, Mustafa MA, Ignatowska-Jankowska BM, Damaj MI, Beardsley PM, Wiley JL, Niphakis MJ, Cravatt BF, Lichtman AH.
    Neuropharmacology; 2017 Oct 01; 125():80-86. PubMed ID: 28673548
    [Abstract] [Full Text] [Related]

  • 11. Δ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in mice.
    Wiebelhaus JM, Grim TW, Owens RA, Lazenka MF, Sim-Selley LJ, Abdullah RA, Niphakis MJ, Vann RE, Cravatt BF, Wiley JL, Negus SS, Lichtman AH.
    J Pharmacol Exp Ther; 2015 Feb 01; 352(2):195-207. PubMed ID: 25398241
    [Abstract] [Full Text] [Related]

  • 12. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
    Lichtman AH, Sheikh SM, Loh HH, Martin BR.
    J Pharmacol Exp Ther; 2001 Sep 01; 298(3):1007-14. PubMed ID: 11504797
    [Abstract] [Full Text] [Related]

  • 13. Full Fatty Acid Amide Hydrolase Inhibition Combined with Partial Monoacylglycerol Lipase Inhibition: Augmented and Sustained Antinociceptive Effects with Reduced Cannabimimetic Side Effects in Mice.
    Ghosh S, Kinsey SG, Liu QS, Hruba L, McMahon LR, Grim TW, Merritt CR, Wise LE, Abdullah RA, Selley DE, Sim-Selley LJ, Cravatt BF, Lichtman AH.
    J Pharmacol Exp Ther; 2015 Aug 01; 354(2):111-20. PubMed ID: 25998048
    [Abstract] [Full Text] [Related]

  • 14. Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling.
    Pan B, Wang W, Long JZ, Sun D, Hillard CJ, Cravatt BF, Liu QS.
    J Pharmacol Exp Ther; 2009 Nov 01; 331(2):591-7. PubMed ID: 19666749
    [Abstract] [Full Text] [Related]

  • 15. Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects.
    Kinsey SG, Wise LE, Ramesh D, Abdullah R, Selley DE, Cravatt BF, Lichtman AH.
    J Pharmacol Exp Ther; 2013 Jun 01; 345(3):492-501. PubMed ID: 23412396
    [Abstract] [Full Text] [Related]

  • 16. Simultaneous inhibition of fatty acid amide hydrolase and monoacylglycerol lipase shares discriminative stimulus effects with Δ9-tetrahydrocannabinol in mice.
    Hruba L, Seillier A, Zaki A, Cravatt BF, Lichtman AH, Giuffrida A, McMahon LR.
    J Pharmacol Exp Ther; 2015 May 01; 353(2):261-8. PubMed ID: 25711338
    [Abstract] [Full Text] [Related]

  • 17. Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice.
    Yamaguchi T, Hagiwara Y, Tanaka H, Sugiura T, Waku K, Shoyama Y, Watanabe S, Yamamoto T.
    Brain Res; 2001 Aug 03; 909(1-2):121-6. PubMed ID: 11478928
    [Abstract] [Full Text] [Related]

  • 18. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
    Spradley JM, Guindon J, Hohmann AG.
    Pharmacol Res; 2010 Sep 03; 62(3):249-58. PubMed ID: 20416378
    [Abstract] [Full Text] [Related]

  • 19. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
    Falenski KW, Thorpe AJ, Schlosburg JE, Cravatt BF, Abdullah RA, Smith TH, Selley DE, Lichtman AH, Sim-Selley LJ.
    Neuropsychopharmacology; 2010 Jul 03; 35(8):1775-87. PubMed ID: 20357755
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of monoacylglycerol lipase reduces nicotine withdrawal.
    Muldoon PP, Chen J, Harenza JL, Abdullah RA, Sim-Selley LJ, Cravatt BF, Miles MF, Chen X, Lichtman AH, Damaj MI.
    Br J Pharmacol; 2015 Feb 03; 172(3):869-82. PubMed ID: 25258021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.